What is the TLT.V share price today?

This page shows the latest available Theralase Technologies Inc. (TLT.V) price with its change against the prior close. Values are delayed or previous-close, not real-time.

Where is Theralase Technologies Inc. listed?

Theralase Technologies Inc. trades on the TSX Venture Exchange under the symbol TLT.V, ISIN CA88337V1004.

How large is Theralase Technologies Inc.?

Its market capitalisation is approximately 56.18M CAD, based on the latest available price and share count from our data provider.

TSX Venture Exchange (TSXV) · TLT.V · ISIN CA88337V1004

Theralase Technologies Inc.

0.1850 CAD

−0.005(−2.63%)

Previous close · Sep 18, 13:54 ET

Data last updated: Sep 18, 13:54 ET (23 h ago)· Delayed exchange data

Theralase Technologies Inc. (TLT.V) trades on the TSX Venture Exchange and operates in the Medical - Devices industry. Its market capitalisation is approximately 56.18M CAD. The company reports around 16 employees. Its ISIN is CA88337V1004. This page shows the latest available price, the day and 52-week ranges and an interactive chart. Quotes are delayed and are not intended for order execution.

Checking today's session…

Key facts

Exchange

TSX Venture Exchange (TSXV)

ISIN

CA88337V1004

Sector

Healthcare

Industry

Medical - Devices

Country

Market cap

54.7M CAD

Employees

Previous close

0.19 CAD

Day range

0.18 – 0.18

52-week range

0.15 – 0.41

Volume

315.42K

50-day average

0.22 CAD

200-day average

0.25 CAD

Asset type

Equity

About Theralase Technologies Inc.

Theralase Technologies Inc., a clinical stage pharmaceutical company, engages in the research, development, and commercialization of light activated photo dynamic compounds and their associated drug formulations to treat cancers, bacteria, and viruses in Canada, the United States, and internationally. The company operates through Drug Division and Device Division segments. It designs, develops, manufactures, and markets super-pulsed laser technology for the healing of chronic knee pain, as well as for off-label use to heal various nerve, muscle, and joint conditions. In addition, the company develops TLD-1433, which is in Phase II clinical trial for the treatment of Bacillus Calmette Guérin-Unresponsive Non-Muscle Invasive Bladder Cancer Carcinoma In-Situ. Further, it researches, develops, manufactures, and distributes controller-less cool laser therapy systems comprising TLC-900, TLC-300, and TLC-100 to healthcare practitioners primarily for the healing of pain. The company has a collaboration with the National Microbiology Laboratory, a Public Health Agency of Canada for the research and development of a Canadian-based SARS-CoV-2 vaccine. Theralase Technologies Inc. is based in Toronto, Canada.

Company website

Frequently asked

What is the TLT.V share price today?: This page shows the latest available Theralase Technologies Inc. (TLT.V) price with its change against the prior close. Values are delayed or previous-close, not real-time.
Where is Theralase Technologies Inc. listed?: Theralase Technologies Inc. trades on the TSX Venture Exchange under the symbol TLT.V, ISIN CA88337V1004.
How large is Theralase Technologies Inc.?: Its market capitalisation is approximately 56.18M CAD, based on the latest available price and share count from our data provider.

All Theralase Technologies Inc. data comes from exchange and provider feeds for the TSX Venture Exchange and is published for information, not as investment advice.

Real-time quotes are not licensed; prices are delayed or previous close, so they may lag the market by 15 minutes or a full session. Information only, not for trading. Where a figure is not covered by our licensed sources, the page says so rather than showing a substitute.